Cart
sales@molnova.com
HS220
CAS No. 1570374-32-1
HS220( —— )
Catalog No. M28488 CAS No. 1570374-32-1
HS220 is an inhibitor of TAK1 which plays a key role in the signaling pathways of inflammation and cell survival.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 112 | In Stock |
|
| 5MG | 106 | In Stock |
|
| 10MG | 169 | In Stock |
|
| 25MG | 280 | In Stock |
|
| 50MG | 365 | In Stock |
|
| 100MG | 498 | In Stock |
|
| 200MG | 684 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHS220
-
NoteResearch use only, not for human use.
-
Brief DescriptionHS220 is an inhibitor of TAK1 which plays a key role in the signaling pathways of inflammation and cell survival.
-
DescriptionHS220 is an inhibitor of TAK1 which plays a key role in the signaling pathways of inflammation and cell survival.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1570374-32-1
-
Formula Weight323.35
-
Molecular FormulaC18H17N3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 83.33 mg/mL (257.71 mM)
-
SMILESO=C(O)C1=CC=CC(=C1)C(=O)NC2=NC=3C=CC=CC3N2CCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CC-99677
CC-99677 (Gamcemetinib) is a selectively targeted covalent MAPKAPK2 (MK2) inhibitor for autoimmune diseases that translates biochemical potency into cellular potency as demonstrated by potent inhibition of heat shock protein 27 (HSP1) phosphorylation in LPS-activated monocyte THP-27 cells via a nucleophilic aromatic substitution (SNAr) mechanism.
-
SB 239063
A potent, selective, orally available p38 MAPK inhibitor with IC50 of 44 nM for both p38α and p38β.
-
Maohuoside A
Maohuoside A promotes osteogenesis of rat mesenchymal stem cells via BMP and MAPK signaling pathways.
